USD 7.71
(-4.76%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -18.37 USD | 63.37% |
2022 | -50.15 USD | 6.84% |
2021 | -53.83 USD | -63006.68% |
2020 | -0.09 USD | -6.09% |
2019 | -0.08 USD | 0.0% |
2001 | - USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -3.31 USD | 0.0% |
2024 Q2 | -4.23 USD | -27.79% |
2023 Q3 | -6.21 USD | -72.98% |
2023 Q1 | -4.28 USD | -12.34% |
2023 FY | - USD | 63.37% |
2023 Q2 | -3.59 USD | 16.12% |
2023 Q4 | - USD | 100.0% |
2022 Q3 | -0.41 USD | 0.0% |
2022 FY | - USD | 6.84% |
2022 Q2 | -0.41 USD | -10.81% |
2022 Q1 | -0.37 USD | 64.76% |
2022 Q4 | -3.81 USD | -829.27% |
2021 FY | - USD | -63006.68% |
2021 Q4 | -1.05 USD | -1212.5% |
2021 Q3 | -0.08 USD | -100.0% |
2021 Q2 | -0.04 USD | 19.19% |
2021 Q1 | -0.05 USD | -56.65% |
2020 Q1 | -3.20 USD | 0.0% |
2020 FY | - USD | -6.09% |
2020 Q3 | -0.02 USD | 99.52% |
2020 Q4 | -0.03 USD | -80.57% |
2020 Q2 | -3.67 USD | -14.69% |
2019 FY | - USD | 0.0% |
2001 Q1 | -0.00 USD | 0.0% |
2001 Q3 | -0.00 USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q2 | -0.00 USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
ADC Therapeutics SA | -2.94 USD | -524.83% |
Alto Neuroscience, Inc. | -1.35 USD | -1260.741% |
Annovis Bio, Inc. | -6.23 USD | -194.864% |
Biohaven Pharmaceutical Holding Company Ltd. | -5.73 USD | -220.593% |
Nuvation Bio Inc. | -0.35 USD | -5148.571% |
Nuvation Bio Inc. | -0.35 USD | -5148.571% |
Arcus Biosciences, Inc. | -4.15 USD | -342.651% |
Zymeworks Inc. | -1.72 USD | -968.023% |